You are here:
Discovery and characterisation of fragment-based, substrate-conjugate inhibitors against a promising anti-neurodegeneration target.
Discovery and characterisation of novel metabolites from NAD+ cleavage and their molecular functions in innate immunity.
Characterisation of a bacterial antiphage system with implications in drug design against bacterial infections.
